Empagliflozin nanoparticles attenuates type2 diabetes induced cognitive impairment via oxidative stress and inflammatory pathway in high fructose diet induced hyperglycemic mice-Reference-Cited by-同舟云学术

Empagliflozin nanoparticles attenuates type2 diabetes induced cognitive impairment via oxidative stress and inflammatory pathway in high fructose diet induced hyperglycemic mice

Published:2021-11 Issue: Volume:150 Page:105158
ISSN:0197-0186
Container-title:Neurochemistry International
language:en
Short-container-title:Neurochemistry International

Author:

Khan Tahira,Khan Sana,Akhtar Mohd^ORCID,Ali Javed,Najmi Abul Kalam

Funder

Indian Council of Medical Research

Publisher

Elsevier BV

Subject

Cell Biology,Cellular and Molecular Neuroscience

Reference59 articles.

1. Diabetes mellitus and risk of Alzheimer disease and decline in cognitive function;Arvanitakis;Arch Neurol,2004

2. Protective effect of irbesartan an angiotensin (AT1) receptor antagonist in unpredictable chronic mild stress induced depression in mice;Ayyub;Drug Res (Stuttg),2017

3. Neuroprotective and anti-ageing effects of curcumin in aged rat brain regions;Bala;Biogerontology,2006

4. Nitric oxide may prevent hypertension early in diabetes by counteracting renal actions of superoxide;Brands;hypertension,2004

5. The role of insulin and insulin-like growth factor I in the molecular and cellular mechanisms underlying the pathology of Alzheimer's disease;Carro;Eur J Pharmacol,2004

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Sodium–Glucose Cotransporter-2 Inhibitors, Dulaglutide, and Risk for Dementia;Annals of Internal Medicine;2024-08-27

2. Unveiling the impact of aging on BBB and Alzheimer's disease: Factors and therapeutic implications;Ageing Research Reviews;2024-07

3. Neuroprotective Effects of Sodium-Glucose Cotransporter-2 (SGLT2) Inhibitors (Gliflozins) on Diabetes-Induced Neurodegeneration and Neurotoxicity: A Graphical Review;International Journal of Preventive Medicine;2024-06

4. Efficacy of empagliflozin as adjunctive therapy to citalopram in major depressive disorder: a randomized double-blind, placebo-controlled clinical trial;BMC Psychiatry;2024-02-26

5. Risks and Benefits of SGLT-2 Inhibitors for Type 1 Diabetes Patients Using Automated Insulin Delivery Systems—A Literature Review;International Journal of Molecular Sciences;2024-02-06